|
1
|
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
|
Nature
|
1998
|
5.98
|
|
2
|
Heterodimerization is required for the formation of a functional GABA(B) receptor.
|
Nature
|
1998
|
5.59
|
|
3
|
Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
|
Mol Pharmacol
|
1999
|
1.89
|
|
4
|
The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat.
|
Endocrinology
|
1983
|
1.19
|
|
5
|
Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.
|
J Pharmacol Exp Ther
|
2000
|
1.13
|
|
6
|
The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.
|
Mol Pharmacol
|
1999
|
1.12
|
|
7
|
Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
|
J Biol Chem
|
2001
|
1.06
|
|
8
|
The influence of cyclosporin a on experimental autoimmune thyroid disease in the rat.
|
Life Sci
|
1983
|
1.02
|
|
9
|
Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
|
Endocrinology
|
1984
|
1.01
|
|
10
|
Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin.
|
J Biol Chem
|
2001
|
0.99
|
|
11
|
Characterization of [3H]-prostaglandin E2 binding to prostaglandin EP4 receptors expressed with Semliki Forest virus.
|
Br J Pharmacol
|
1997
|
0.98
|
|
12
|
Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
|
Biochem Biophys Res Commun
|
2000
|
0.92
|
|
13
|
Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
|
Endocrinology
|
1986
|
0.88
|
|
14
|
Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
|
Endocrinology
|
1983
|
0.85
|
|
15
|
Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells.
|
FEBS Lett
|
1998
|
0.84
|
|
16
|
Mutagenesis of human Mel1a melatonin receptor expressed in yeast reveals domains important for receptor function.
|
Biochem Biophys Res Commun
|
1998
|
0.83
|
|
17
|
GR196429: a nonindolic agonist at high-affinity melatonin receptors.
|
J Pharmacol Exp Ther
|
1998
|
0.81
|
|
18
|
Transgenic gene knock-outs: functional genomics and therapeutic target selection.
|
Pharmacogenomics
|
2000
|
0.80
|
|
19
|
The CGRP receptor can couple via pertussis toxin sensitive and insensitive G proteins.
|
FEBS Lett
|
1998
|
0.78
|
|
20
|
The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells.
|
Endocrinology
|
1985
|
0.78
|
|
21
|
Dopaminergic control of TSH secretion in isolated rat pituitary cells.
|
FEBS Lett
|
1980
|
0.77
|
|
22
|
Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells.
|
J Biol Chem
|
1985
|
0.76
|
|
23
|
Interactions among epinephrine, thyrotropin (TSH)-releasing hormone, dopamine, and somatostatin in the control of TSH secretion in vitro.
|
Endocrinology
|
1984
|
0.76
|
|
24
|
Dopaminergic inhibition of thyrotropin secretion.
|
Biochem Soc Trans
|
1980
|
0.75
|
|
25
|
Relationships between the circadian rhythms of TSH, prolactin and cortisol in surgically treated microprolactinoma patients.
|
Clin Endocrinol (Oxf)
|
1985
|
0.75
|
|
26
|
Alpha 1-adrenoreceptors and alpha 1-adrenoreceptor-mediated thyrotropin release in cultures of euthyroid and hypothyroid rat anterior pituitary cells.
|
Endocrinology
|
1985
|
0.75
|
|
27
|
Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia.
|
J Endocrinol Invest
|
1985
|
0.75
|
|
28
|
The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patients.
|
Clin Endocrinol (Oxf)
|
1985
|
0.75
|
|
29
|
The role of calcium and calmodulin in mediating release of thyrotrophin-releasing hormone by cultured hypothalamic cells.
|
J Endocrinol
|
1987
|
0.75
|
|
30
|
The effects of long term growth hormone releasing factor (GRF 1-40) administration on growth hormone secretion and synthesis in vitro.
|
Biochem Biophys Res Commun
|
1984
|
0.75
|
|
31
|
Rat anterior pituitary cells maintained on artificial capillaries: responses of thyrotrophs and lactotrophs to depolarization, TRH and dopamine.
|
Mol Cell Endocrinol
|
1984
|
0.75
|
|
32
|
Differential production of SRIF 14 and 28 by fetal rat hypothalamic cells enriched by velocity sedimentation.
|
Neuroendocrinology
|
1986
|
0.75
|
|
33
|
Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
|
J Clin Endocrinol Metab
|
1983
|
0.75
|
|
34
|
TSH neuroregulation and alterations in disease states.
|
Clin Endocrinol Metab
|
1983
|
0.75
|
|
35
|
Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture.
|
Endocrinology
|
1984
|
0.75
|
|
36
|
Alpha 1-adrenoreceptors on intact rat anterior pituitary cells: correlation with adrenergic stimulation of thyrotropin secretion.
|
Endocrinology
|
1983
|
0.75
|
|
37
|
Expression and function of the human calcitonin/alpha-CGRP gene in health and disease.
|
Biochem Soc Symp
|
1986
|
0.75
|